Clinical Trials Directory

Trials / Completed

CompletedNCT03777046

Maternal Mental Health in the Hospital Setting

Addressing Maternal Mental Health Needs During Pediatric Acute Care Hospitalizations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
545 (actual)
Sponsor
Michelle Lopez · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Perinatal (around the time of birth) mental health disorders are common difficulties of pregnancy. Perinatal depression is made up of major and minor depressive events during pregnancy and the first 12 months after delivery. It is estimated that 11%-19% of mothers suffer from perinatal depression. However, rates may be significantly higher among some subpopulations. Left untreated, post partum depression (PPD) is linked with several significant negative health impacts on the mother, her infant, and their families. PPD is linked with lower quality maternal-child relationship, and this change in emotional attachment can lead to physiologic changes and poorer cognitive outcomes in the infant. The purpose of this study is to determine the maternal mental health effect of postpartum depression screening and intervention during infants' short term hospitalizations. The study is also aiming to define effects of PPD short term hospitalization interventions on maternal PPD follow up and child health based on well child care (WCC), emergency department (ED) visits, hospital readmissions, and parent's feelings on child's health.

Detailed description

Study participants will complete a survey about their general needs and access to resources and a survey to screen for postpartum depression to determine if the participant will be enrolled. Based on the answers provided, the study team may recommend that the participant seek additional medical care, and may notify the participant's doctor, the child's doctor, and hospital officials if the study team believes that the participant needs further medical care for depression. Half of the study participants will receive a social work consult and treatment with psychology therapy in the hospital. The psychology therapy will be 2-3 fifty-minute therapy sessions while the child is in the hospital. An outpatient psychiatry/psychology follow up appointment will be offered if needed as per routine care. Discharge Follow Up: A discharge follow up questionnaire and survey will be completed on an electronic tablet around the time of the baby's discharge home from the hospital or within 1 week of being at home. The survey can be completed over the phone or it can be sent via email or text to complete the survey online. One Month Follow Up: A one-time follow up questionnaire and survey will be completed 1 month after discharge from the hospital. The survey can be completed in approximately 5 - 10 minutes over the phone or it can be sent via email or text to complete the survey online. The other half of the study participants will receive social work consult with information about follow up options for PPD per current standard of care for mothers identified as having postpartum depression in the hospital setting. As part of this study a review of the child's medical record, including data collection, will be performed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALStandard of Care (SOC)Mothers that meet inclusion criteria for the study, that score 10 or more on the Edinburgh Postpartum Depression Scale (EPDS) that will receive Standard of care treatment. SOC treatment includes social work consult with information about follow up options for PPD.
BEHAVIORALSOC with Psychology Therapy (CBT)Mothers that meet inclusion criteria for the study, that score 10 or more on the Edinburgh Postpartum Depression Scale (EPDS) that will receive the experimental intervention. Intervention includes SOC treatment as well as psychology therapy (CBT) in the hospital.

Timeline

Start date
2019-01-24
Primary completion
2020-03-13
Completion
2020-05-22
First posted
2018-12-17
Last updated
2023-02-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03777046. Inclusion in this directory is not an endorsement.